The aim of this research is to study statistically erysipelas cases and its precipitating factors and also to determine the possibility of considering intramuscular injection of lincomycin as an effective treatment of uncomplicated erysipelas instead
of intravenous penicillin G.
60 cases of erysipelas were studied and evaluated. There was no significant relation to age, sex and site of infection. The most affected sites were lower limbs, then face, and upper limbs.
The most important risk factors were fungal intertrigo, vascular impairment and finally diabetes mellitus.
The response to lincomycin treatment was excellent in 71.71%, intermediate in 23.91% of patients, while there was no response in only 4.34% of cases.
